Nexavar significantly boosts hypertension risk: study (Reuters)
Date : 2008 01 21 Category : Health
Reuters - Bayer AG and Onyx Pharmaceutical Inc.'s
key cancer drug Nexavar significantly raises the risk of high
blood pressure, U.S. researchers said on Tuesday.